Will covid-19 vaccines save lives? Current trials aren’t designed to tell us.

We thank the BMJ for their generous sharing policies during these unprecedented times. In the below article, Peter Doshi, associate editor of the BMJ, explains how COVID-19 trials are designed, and why they won’t provide the answers needed to show effectiveness or safety.

The recovery data clearly shows vaccines targeting SARS-COV-2 are not necessary. When an infection has 99.9+% recovery rates for the vast majority of the population, treatments are the ethical tools for public health to support.

Loader Loading…
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab
Print Friendly, PDF & Email
close

Like what you learned? Subscribe to our Feed to get email notice of new posts.

Get new posts by email: